Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Bullboard (NDAQ:GALE)

View:
1 2 3 4 Next
Comment by Stockhudsonon Jan 09, 2017 10:56am

RE:technicals

is this a buy signal
138
Discussion
Post by mumu55on Jun 17, 2014 10:10am

NEWS today GALE

Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and ...more  
272
Post by Highrider7on Feb 20, 2014 10:12am

SHAREHOLDER ALERT !!!

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of GALENA BIOPHARMA, INC. for Possible Breaches of Fiduciary Duty 18 Feb 2014 - ACQUIREMEDIA NEW YORK--(BUSINESS WIRE)--Feb. 18 ...more  
232
Post by Highrider7on Feb 14, 2014 11:43am

GALENA'S DROPPING AND SHE AIN'T STOPPING !!

Wow ... what a trading opportunity. Up and down like a yo-yo. Right now Galena is dropping and she ain't stopping. Down over another 20 % so far today. Broke down through the $ 3.85 ( approx ...more  
220
Post by Highrider7on Feb 10, 2014 4:23pm

NICE MOVE

Nice move.   The way it has been trading the last couple of days it looks like it could continue the run for awhile yet.  Up another 9.33 % today alone.....   ...more  
229
Post by MissionIRon Feb 06, 2014 5:52pm

Galena Biopharma, Inc. (GALE) to Deliver Presentation at the

Galena Biopharma, Inc. (GALE) to Deliver Presentation at the 2014 Leerink Global Healthcare Conference Today before the opening bell, Galena Biopharma announced that Mark J. Ahn, Ph.D., President and ...more  
158
Post by MissionIRon Feb 05, 2014 7:18pm

Seeking Alpha Contributor Explains His Long Stance on Galena

Seeking Alpha Contributor Explains His Long Stance on Galena Biopharma (GALE) In a Seeking Alpha article discussing the “pipeline potential” of Galena Biopharma, writer and ...more  
180
Post by MissionIRon Feb 04, 2014 3:01pm

Galena Biopharma, Inc. (GALE) Presenting at 16th Annual BIO

Galena Biopharma, Inc. (GALE) Presenting at 16th Annual BIO CEO & Investor Conference Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology ...more  
117
Post by MissionIRon Feb 03, 2014 6:58pm

Galena Biopharma, Inc. (GALE) Pipeline Products Include Immu

Galena Biopharma, Inc. (GALE) Pipeline Products Include Immunotherapy Cancer Treatments Galena Biopharma is focused on discovering, developing, and commercializing innovative therapies addressing ...more  
173
Post by MissionIRon Jan 24, 2014 11:35pm

Two Analysts Hike Price Target of Galena Biopharma, Inc. (GA

Two Analysts Hike Price Target of Galena Biopharma, Inc. (GALE) Stock Following Acquisition, Advancement The hard work Galena Biopharma is investing in the development and expansion of its clinical ...more  
223
Post by MissionIRon Jan 14, 2014 6:08pm

Galena Biopharma, Inc. (GALE) Partners with Dr. Reddy’s Labo

Galena Biopharma, Inc. (GALE) Partners with Dr. Reddy’s Laboratories Ltd. (RDY) to Broaden Geographic Reach and Addressable Patient Population of NeuVax Today before the opening bell, it was ...more  
164
Post by MissionIRon Jan 13, 2014 6:53pm

Galena Biopharma, Inc. (GALE) Expands Product Pipeline with

Galena Biopharma, Inc. (GALE) Expands Product Pipeline with Acquisition of Mills Pharmaceuticals, LLC Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted ...more  
129
Post by MissionIRon Jan 07, 2014 7:22pm

Galena Biopharma, Inc. (GALE) Enrolls First Patient in Phase

Galena Biopharma, Inc. (GALE) Enrolls First Patient in Phase 2 Trial for Endometrial, Ovarian Cancer Vaccine Galena Biopharma, a biopharmaceutical company developing oncology treatments to advance ...more  
194
Post by MissionIRon Jan 02, 2014 4:19pm

Galena Biopharma, Inc. (GALE) Gets Multiple Mentions as Biot

Galena Biopharma, Inc. (GALE) Gets Multiple Mentions as Biotech Hot Stock; Set Up for Strong 2014 In the annual slew of evaluations of year-long stock performances, Galena Biopharma emerged as a ...more  
262
Post by MissionIRon Dec 19, 2013 8:08pm

Seeking Alpha Contributor Ponders Factors to Sustain Galena

Seeking Alpha Contributor Ponders Factors to Sustain Galena Biopharma’s (GALE) Triple-Digit Gains The end of a year inherently triggers a mental account of the good and bad ...more  
186
1 2 3 4 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities